Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Organogenesis Holdings (ORGO) EBIAT (2016 - 2025)

Organogenesis Holdings (ORGO) has 10 years of EBIAT data on record, last reported at $43.7 million in Q4 2025.

  • For Q4 2025, EBIAT rose 469.53% year-over-year to $43.7 million; the TTM value through Dec 2025 reached $37.0 million, up 4201.05%, while the annual FY2025 figure was $37.0 million, 4201.05% up from the prior year.
  • EBIAT reached $43.7 million in Q4 2025 per ORGO's latest filing, up from $21.6 million in the prior quarter.
  • Across five years, EBIAT topped out at $51.0 million in Q4 2021 and bottomed at -$18.8 million in Q1 2025.
  • Average EBIAT over 5 years is $7.6 million, with a median of $6.4 million recorded in 2022.
  • Peak YoY movement for EBIAT: surged 1450.88% in 2024, then plummeted 797.29% in 2025.
  • A 5-year view of EBIAT shows it stood at $51.0 million in 2021, then plummeted by 85.32% to $7.5 million in 2022, then plummeted by 107.59% to -$568000.0 in 2023, then soared by 1450.88% to $7.7 million in 2024, then soared by 469.53% to $43.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were $43.7 million in Q4 2025, $21.6 million in Q3 2025, and -$9.4 million in Q2 2025.